集成18F-FDG PET/MRI中PET与MR数据集的评估:不同MR序列用于乳腺癌患者全身再分期的比较
前瞻性纳入36例疑肿瘤复发的乳腺癌患者,均行PET/CT后追加PET/MR扫描,比较不同MR序列及PET数据的诊断价值。结果显示全部三种PET/MRI阅片方案的准确性和置信度均显著高于单独MRI(p<0.05),三种方案间诊断准确性相当(p>0.05);对比增强T1加权VIBE对病灶显示显著优于T2w HASTE和DWI。
要点
- 全部三种PET/MRI阅片方案对复发灶的诊断准确性和置信度均显著高于单独MRI(p<0.05)。
- 三种PET/MR序列组合之间诊断准确性相当(p>0.05),三序列联合时置信度最高。
- 对比增强T1加权VIBE对恶性和良性病灶的显示显著优于T2w HASTE和DWI。
核心结论
- 集成PET/MRI对乳腺癌患者的再分期优于单独MRI;快速且形态学充分的PET/MR方案具有可行性;鉴于三种PET/MR阅片方案诊断准确性相当,对比剂应用和纳入DWI似有讨论余地。
研究设计与样本
- 前瞻性研究,纳入36例基于临床随访或随访检查(如CT、MRI)异常发现怀疑肿瘤复发的乳腺癌患者,全部行PET/CT后追加PET/MR扫描;两名阅片者分别在不同MR序列组合下判读MR和PET/MR。
诊断标准与关键数值
- 对每个病灶的恶性或良性判定置信度采用3点序数量表定性评分。
- 三种不同MR序列的病灶显示清晰度采用4点序数量表评估。
- 三种PET/MRI阅片方案的准确性及置信度均显著高于单独MRI(p<0.05)。
- 三种PET/MR序列组合之间诊断准确性相当(p>0.05)。
- 对比增强T1加权VIBE对恶性和良性病灶的显示值显著高于T2w HASTE和DWI。
临床应用与阅片要点
- 集成PET/MRI较单独MRI可提供更优的乳腺癌再分期。
- 快速且形态学充分的PET/MR方案具有可行性。
- 作者认为,鉴于三种PET/MR阅片方案诊断准确性相当,对比剂应用和纳入DWI似有讨论余地。
局限性
- 作者指出,鉴于三种PET/MR阅片方案诊断准确性相当,对比剂应用和纳入DWI似有讨论余地。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the diagnostic value of different MR sequences and 18F-FDG PET data for whole-body restaging of breast cancer patients utilizing PET/MRI.
METHODS: A total of 36 patients with suspected tumor recurrence of breast cancer based on clinical follow-up or abnormal findings in follow-up examinations (e.g. CT, MRI) were prospectively enrolled in this study. All patients underwent a PET/CT and subsequently an additional PET/MR scan. Two readers were instructed to identify the occurrence of a tumor relapse in subsequent MR and PET/MR readings, utilizing different MR sequence constellations for each session. The diagnostic confidence for the determination of a malignant or benign lesion was qualitatively rated (3-point ordinal scale) for each lesion in the different reading sessions and the lesion conspicuity (4-point ordinal scale) for the three different MR sequences was additionally evaluated.
RESULTS: Tumor recurrence was present in 25/36 (69%) patients. All three PET/MRI readings showed a significantly higher accuracy as well as higher confidence levels for the detection of recurrent breast cancer lesions when compared to MRI alone (p<0.05). Furthermore, all three PET/MR sequence constellations showed comparable diagnostic accuracy for the identification of a breast cancer recurrence (p>0.05), yet the highest confidence levels were obtained, when all three MR sequences were used for image interpretation. Moreover, contrast-enhanced T1-weighted VIBE imaging showed significantly higher values for the delineation of malignant and benign lesions when compared to T2w HASTE and diffusion-weighted imaging.
CONCLUSION: Integrated PET/MRI provides superior restaging of breast cancer patients over MRI alone. Facing the need for appropriate and efficient whole-body PET/MR protocols, our results show the feasibility of fast and morphologically adequate PET/MR protocols. However, considering an equivalent accuracy for the detection of breast cancer recurrences in the three PET/MR readings, the application of contrast-agent and the inclusion of DWI in the study protocol seems to be debatable.
引用
- Grueneisen J, Sawicki LM, Wetter A, et al. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients. Eur J Radiol. 2017. PMID: 28267530. doi:10.1016/j.ejrad.2016.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。